Breast Cancer Drug Benefits Broader Group of Patients, Trial Shows
Newswise — DALLAS – Oct. 28, 2022 – A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic…
Read more Breast Cancer Drug Benefits Broader Group of Patients, Trial Shows